Literature DB >> 8858953

Specific delay in the degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis is derived from cellular proteolytic dysfunction rather than structural alteration of subunit c.

J Ezaki1, L S Wolfe, E Kominami.   

Abstract

Previously we indicated that a specific delay in subunit c degradation causes the accumulation of mitochondrial ATP synthase subunit c in lysosomes from the cells of patients with the late infantile form of neuronal ceroid lipofuscinosis (NCL). To explore the mechanism of lysosomal storage of subunit c in patient cells, we investigated the mechanism of the lysosomal accumulation of subunit c both in cultured normal fibroblasts and in in vitro cell-free incubation experiments. Addition of pepstatin to normal fibroblasts causes the marked lysosomal accumulation of subunit c and less accumulation of Mn(2+)-superoxide dismutase (SOD). In contrast, E-64-d stimulates greater lysosomal storage of Mn(2+)-SOD than of subunit c. Incubation of mitochondrial-lysosomal fractions from control and diseased cells at acidic pH leads to a much more rapid degradation of subunit c in control cells than in diseased cells, whereas other mitochondrial proteins, including Mn(2+)-SOD, beta subunit of ATP synthase, and subunit i.v. of cytochrome oxidase, are degraded at similar rates in both control and patient cells. The proteolysis of subunit c in normal cell extracts is inhibited markedly by pepstatin and weakly by E-64-c, as in the cultured cell experiments. However, there are no differences in the lysosomal protease levels, including the levels of the pepstatin-sensitive aspartic protease cathepsin D between control and patient cells. The stable subunit c in mitochondrial-lysosomal fractions from patient cells is degraded on incubation with mitochondrial-lysosomal fractions from control cells. Exchange experiments using radiolabeled substrates and nonlabeled proteolytic sources from control and patient cells showed that proteolytic dysfunction, rather than structural alterations such as the posttranslational modification of subunit c, is responsible for the specific delay in the degradation of subunit c in the late infantile form of NCL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858953     DOI: 10.1046/j.1471-4159.1996.67041677.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Authors:  Lakshya Bajaj; Jaiprakash Sharma; Alberto di Ronza; Pengcheng Zhang; Aiden Eblimit; Rituraj Pal; Dany Roman; John R Collette; Clarissa Booth; Kevin T Chang; Richard N Sifers; Sung Y Jung; Jill M Weimer; Rui Chen; Randy W Schekman; Marco Sardiello
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons.

Authors:  M Koike; H Nakanishi; P Saftig; J Ezaki; K Isahara; Y Ohsawa; W Schulz-Schaeffer; T Watanabe; S Waguri; S Kametaka; M Shibata; K Yamamoto; E Kominami; C Peters; K von Figura; Y Uchiyama
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.

Authors:  M J Warburton; F Bernardini
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

4.  Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.

Authors:  Mario de la Mata; David Cotán; Manuel Oropesa-Ávila; Juan Garrido-Maraver; Mario D Cordero; Marina Villanueva Paz; Ana Delgado Pavón; Elizabet Alcocer-Gómez; Isabel de Lavera; Patricia Ybot-González; Ana Paula Zaderenko; Carmen Ortiz Mellet; José M García Fernández; José A Sánchez-Alcázar
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

5.  Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease.

Authors:  Mario de la Mata; David Cotán; Manuel Oropesa-Ávila; Marina Villanueva-Paz; Isabel de Lavera; Mónica Álvarez-Córdoba; Raquel Luzón-Hidalgo; Juan M Suárez-Rivero; Gustavo Tiscornia; José A Sánchez-Alcázar
Journal:  Orphanet J Rare Dis       Date:  2017-02-06       Impact factor: 4.123

Review 6.  Lysosomes as a therapeutic target.

Authors:  Srinivasa Reddy Bonam; Fengjuan Wang; Sylviane Muller
Journal:  Nat Rev Drug Discov       Date:  2019-09-02       Impact factor: 84.694

7.  Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease.

Authors:  Li Ma; Adriana M Prada; Michael Schmidt; Eric M Morrow
Journal:  Stem Cell Res       Date:  2021-04-06       Impact factor: 1.587

Review 8.  The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Authors:  Frances M Platt; Barry Boland; Aarnoud C van der Spoel
Journal:  J Cell Biol       Date:  2012-11-26       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.